{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:54:53Z","timestamp":1791248093539,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Grant-in-Aid for Young Scientists","award":["22790170"],"award-info":[{"award-number":["22790170"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.leukres.2011.11.015","type":"journal-article","created":{"date-parts":[[2011,12,24]],"date-time":"2011-12-24T16:37:02Z","timestamp":1324744622000},"page":"560-564","source":"Crossref","is-referenced-by-count":34,"title":["The activity of the inosine triphosphate pyrophosphatase affects toxicity of 6-mercaptopurine during maintenance therapy for acute lymphoblastic leukemia in Japanese children"],"prefix":"10.1016","volume":"36","author":[{"given":"Yoichi","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Manabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisaya","family":"Nakadate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Kondoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kozue","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyoshi","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Utano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Komiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.leukres.2011.11.015_bib0005","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/sj.leu.2402259","article-title":"Possible implication of thiopurine S-methyltransferase in occurrence of infectious episodes during maintenance therapy for childhood lymphoblastic leukemia with mercaptopurine","volume":"15","author":"Dervieux","year":"2001","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.leukres.2011.11.015_bib0010","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s12032-009-9331-8","article-title":"Frequency of TPMT alleles in Indian patients with acute lymphatic leukemia and effect on the dose of 6-mercaptopurine","volume":"27","author":"Desire","year":"2010","journal-title":"Med Oncol"},{"issue":"6","key":"10.1016\/j.leukres.2011.11.015_bib0015","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/01.ftd.0000249947.17676.92","article-title":"Analysis of thiopurine S-methyltransferase polymorphism in the population of Serbia and Montenegro and mercaptopurine therapy tolerance in childhood acute lymphoblastic leukemia","volume":"28","author":"Dokmanovic","year":"2006","journal-title":"Ther Drug Monit"},{"issue":"8","key":"10.1016\/j.leukres.2011.11.015_bib0020","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.leukres.2010.01.029","article-title":"Thiopurine S-methyltransferase gene polymorphism and 6-mercaptopurine dose intensity in Indian children with acute lymphoblastic leukemia","volume":"34","author":"Kapoor","year":"2010","journal-title":"Leuk Res"},{"issue":"23","key":"10.1016\/j.leukres.2011.11.015_bib0025","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/jnci\/91.23.2001","article-title":"Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus","volume":"91","author":"Relling","year":"1999","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.leukres.2011.11.015_bib0030","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00008571-200104000-00011","article-title":"Genetic polymorphisms of thiopurine S-methyltransferase and 6-mercaptopurine toxicity in Japanese children with acute lymphoblastic leukaemia","volume":"11","author":"Ando","year":"2001","journal-title":"Pharmacogenetics"},{"issue":"4","key":"10.1016\/j.leukres.2011.11.015_bib0035","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2125.2008.03248.x","article-title":"Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine","volume":"66","author":"Hawwa","year":"2008","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.leukres.2011.11.015_bib0040","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1365-2125.1997.t01-1-00607.x","article-title":"Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity","volume":"44","author":"Lennard","year":"1997","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.leukres.2011.11.015_bib0045","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2125.2001.01371.x","article-title":"Frequencies of thiopurine S-methyltransferase mutant alleles (TPMT*2, *3A, *3B and *3C) in 151 healthy Japanese subjects and the inheritance of TPMT*3C in the family of a propositus","volume":"51","author":"Kubota","year":"2001","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.leukres.2011.11.015_bib0050","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00008571-200104000-00012","article-title":"Allelotype frequency of the thiopurine methyltransferase (TPMT) gene in Japanese","volume":"11","author":"Kumagai","year":"2001","journal-title":"Pharmacogenetics"},{"issue":"1","key":"10.1016\/j.leukres.2011.11.015_bib0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1517\/14740330903426151","article-title":"Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status","volume":"9","author":"Stocco","year":"2010","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"10.1016\/j.leukres.2011.11.015_bib0060","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00008571-200403000-00006","article-title":"Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase)","volume":"14","author":"Marinaki","year":"2004","journal-title":"Pharmacogenetics"},{"issue":"3","key":"10.1016\/j.leukres.2011.11.015_bib0065","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00521144","article-title":"Genetic studies of human erythrocyte inosine triphosphatase","volume":"3","author":"Vanderheiden","year":"1969","journal-title":"Biochem Genet"},{"issue":"4","key":"10.1016\/j.leukres.2011.11.015_bib0070","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ymgme.2005.03.011","article-title":"Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency in the Japanese population","volume":"85","author":"Maeda","year":"2005","journal-title":"Mol Genet Metab"},{"issue":"4\u20135","key":"10.1016\/j.leukres.2011.11.015_bib0075","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00439-002-0798-z","article-title":"Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency","volume":"111","author":"Sumi","year":"2002","journal-title":"Hum Genet"},{"issue":"2","key":"10.1016\/j.leukres.2011.11.015_bib0080","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1023\/B:BOLI.0000028838.24871.8e","article-title":"A Japanese case with inosine triphosphate pyrophosphohydrolase deficiency attributable to an enzymatic defect in white blood cells","volume":"27","author":"Sumi","year":"2004","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"10.1016\/j.leukres.2011.11.015_bib0085","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/clpt.2008.261","article-title":"Pro32Thr polymorphism of inosine triphosphate pyrophosphatase gene predicts efficacy of low-dose azathioprine for patients with systemic lupus erythematosus","volume":"85","author":"Okada","year":"2009","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.leukres.2011.11.015_bib0090","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/clpt.2008.154","article-title":"Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia","volume":"85","author":"Stocco","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.leukres.2011.11.015_bib0095","series-title":"Common terminology criteria for adverse events, version 2.0 (CTCAE)","author":"Institute NC","year":"1999"},{"issue":"2","key":"10.1016\/j.leukres.2011.11.015_bib0100","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1373\/clinchem.2005.059501","article-title":"Measurement of erythrocyte inosine triphosphate pyrophosphohydrolase (ITPA) activity by HPLC and correlation of ITPA genotype\u2013phenotype in a Caucasian population","volume":"52","author":"Shipkova","year":"2006","journal-title":"Clin Chem"},{"issue":"9","key":"10.1016\/j.leukres.2011.11.015_bib0105","doi-asserted-by":"crossref","first-page":"716","DOI":"10.7326\/0003-4819-129-9-199811010-00007","article-title":"Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine","volume":"129","author":"Black","year":"1998","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.leukres.2011.11.015_bib0110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrc1800","article-title":"Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy","volume":"6","author":"Cheok","year":"2006","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.leukres.2011.11.015_bib0115","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/clpt.1989.119","article-title":"Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism","volume":"46","author":"Lennard","year":"1989","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.leukres.2011.11.015_bib0120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/j.seminhematol.2008.09.002","article-title":"Pharmacogenetics in acute lymphoblastic leukemia","volume":"46","author":"Cheok","year":"2009","journal-title":"Semin Hematol"},{"key":"10.1016\/j.leukres.2011.11.015_bib0125","unstructured":"Wan Rosalina WR, Teh LK, Mohamad N, et al. Polymorphism of ITPA 94C>A and risk of adverse effects among patients with acute lymphoblastic leukaemia treated with 6-mercaptopurine. J Clin Pharm Ther, in press."},{"issue":"3","key":"10.1016\/j.leukres.2011.11.015_bib0130","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/FTD.0b013e31821a7c34","article-title":"Association between adverse effects under azathioprine therapy and inosine triphosphate pyrophosphatase activity in patients with chronic inflammatory bowel disease","volume":"33","author":"Shipkova","year":"2011","journal-title":"Ther Drug Monit"},{"issue":"3","key":"10.1016\/j.leukres.2011.11.015_bib0135","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00535-008-2307-1","article-title":"Thiopurine S-methyltransferase and inosine triphosphate pyrophosphohydrolase genes in Japanese patients with inflammatory bowel disease in whom adverse drug reactions were induced by azathioprine\/6-mercaptopurine treatment","volume":"44","author":"Uchiyama","year":"2009","journal-title":"J Gastroenterol"},{"issue":"5","key":"10.1016\/j.leukres.2011.11.015_bib0140","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00228-009-0630-y","article-title":"TPMT but not ITPA gene polymorphism influences the risk of azathioprine intolerance in renal transplant recipients","volume":"65","author":"Kurzawski","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.leukres.2011.11.015_bib0145","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.clpt.2003.12.001","article-title":"Methylated metabolites of 6-mercaptopurine are associated with hepatotoxicity","volume":"75","author":"Nygaard","year":"2004","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.leukres.2011.11.015_bib0150","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2125.2010.03867.x","article-title":"Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy","volume":"71","author":"Adam de Beaumais","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.leukres.2011.11.015_bib0155","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0016-5085(00)70140-5","article-title":"Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease","volume":"118","author":"Dubinsky","year":"2000","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.leukres.2011.11.015_bib0160","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10038-004-0183-y","article-title":"Distribution of ITPA P32T alleles in multiple world populations","volume":"49","author":"Marsh","year":"2004","journal-title":"J Hum Genet"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611005650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611005650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T14:21:17Z","timestamp":1543328477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212611005650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0145212611005650"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2011.11.015","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}